作者: Anna Carolina Ratto Tempestini Horliana , Raquel Agnelli Mesquita Ferrari , Sandra Kalil Bussadori , Lara J Motta , Kristianne P Santos Fernandes
DOI: 10.1136/BMJOPEN-2017-018326
关键词:
摘要: Introduction Epidemiological data show that the signs and symptoms of temporomandibular disorder (TMD) start becoming apparent from 6 years age, during adolescence these are similar to those adults. The present study aims estimate direct costs for treatment chronic muscle pain with photobiomodulation therapy, occlusal splint placebo in patients TMD; evaluate effectiveness therapy analyse cost-effectiveness two proposed treatments pain; describe compare results analyses treatments. Methods analysis This is a prospective trial clinical economic will include 135 patientswith TMD aged between 15 years 25 years, randomly assigned group: G1 (photobiomodulation), G2 (occlusal splint) G3 (placebo). be based on cost each 12-month period. outcome pain, measured periodically by means examination Research Diagnostic Criteria Temporomandibular Disorders. ratio calculated using, as end points, differences groups studied. evaluation impact quality life determined applying adapted EuroQol-5D. Ethics dissemination protocol has been ethically approved local medical ethical committee, number 2.014.339. Results submitted international peer-reviewed journals presented at conferences. Trial registration NCT03096301.